Versant Ventures VII GP-GP, LLC, 10% Owner at LENZ Therapeutics, Inc. (LENZ), sold 191,376 shares at $34.00 ($6.5M) on 2025-07-10, disclosed to the SEC on 2025-07-14.
Open-market sale of $6.5M LENZ by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.